Context Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	157	18	10	42	-	-
Market Cap Growth	145.46%	73.39%	-75.50%	-	-	-
Enterprise Value	149	4	-25	-7	6	22
PE Ratio	-	-0.75	-0.70	-4.06	-	-
PB Ratio	18.83	1.52	0.30	0.88	-	-
P/FCF Ratio	-1.12	-0.86	-0.77	-4.83	-	-
P/OCF Ratio	-1.12	-0.86	-0.77	-4.83	-	-
EV/EBITDA Ratio	-0.56	-0.15	1.70	0.69	0.77	-4.09
EV/EBIT Ratio	-0.56	-0.15	1.69	0.69	0.77	-4.09
EV/FCF Ratio	-0.61	-0.17	1.84	0.82	-5.42	-7.62
Debt / Equity Ratio	-	-	0.00	-	-0.35	-0.91
Debt / EBITDA Ratio	-	-	0.00	-	0.81	-4.13
Debt / FCF Ratio	-	-	0.00	-	-5.75	-7.70
Quick Ratio	3.87	3.45	11.07	16.38	0.04	0.01
Current Ratio	4.23	3.83	11.80	16.90	0.03	0.01
Interest Coverage	-	-	-	-161.78	11.05	-4.80
Return on Equity (ROE)	-136.00%	-115.50%	-37.10%	284.10%	-32.50%	-
Return on Assets (ROA)	-109.50%	-97.00%	-34.50%	-71.50%	1793.60%	-
Return on Capital (ROIC)	-264.09%	-211.68%	-44.19%	-21.55%	23.45%	253.90%
Earnings Yield	-13.41%	-132.83%	-142.58%	-24.62%	-	-
FCF Yield	-12.38%	-116.66%	-130.57%	-20.72%	-	-
Buyback Yield / Dilution	-	-463.44%	-37.90%	-	-
Total Shareholder Return	-	-463.44%	-37.90%	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).